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Abstract
Background: Palpable breast lump, breast pain, and nipple discharge are common symptoms of breast disease.
Breast cytology (fine-needle aspiration, nipple discharge smear, and touch preparation) accurately identifies benign,
atypical, and malignant pathological changes in breast specimens. This study aims to determine the types of breast
lesions diagnosed by breast cytology and assess the clinical adequacy of narrative reporting of breast cytology
results.
Methods: Medical records of 390 patients presenting to breast or general surgery clinics in Kenyatta National
Hospital, Nairobi, Kenya, between January 2010 and March 2014 were evaluated retrospectively.
Results: Of the 390 diagnosed breast lesions, 89.7 % (n = 350) occurred in females, while 10.3 % (n = 40) occurred
in males, giving rise to a female-to-male ratio of 8.8:1. Neoplastic breast lesions (n = 296) comprised 75.9 %, while
non-neoplastic breast lesions (n = 94) comprised 24.1 % of all diagnosed breast lesions. The neoplastic lesions were
classified as 72.3 % (n = 214) benign and 27.7 % (n = 82) malignant, resulting in a benign-to-malignant ratio of 2.6:1.
Fibroadenoma (n = 136) and gynecomastia (n = 33) were the most frequently diagnosed breast lesions for women
and men, respectively.
Conclusions: Breast cytology effectively diagnosed neoplastic and non-neoplastic breast lesions. Neoplastic breast
lesions occurred more frequently in women whereas non-neoplastic lesions occurred more frequently in men. To
address the limitations associated with narrative reporting of breast cytology results, a synoptic reporting format
incorporating the United Kingdom’s National Health Service Breast Screening Programme’s diagnostic categories
(C1 to C5) is recommended for adoption by this hospital.
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Background
Palpable breast lump, breast pain, and nipple discharge
are common manifestations of benign, premalignant, or
malignant lesions in the human mammary gland and
surrounding tissues [1–4]. Techniques used to diagnose
breast lesions include clinical breast examination, breast
imaging, and breast cytology [2, 4]. Fine-needle aspir-
ation cytology is the most reliable component of this
triple test assessment of breast lesions due to its high
sensitivity, specificity, negative predictive value, and
positive predictive value [3, 5].
Malignant and benign breast diseases are prevalent in
girls and women in Sub-Saharan Africa [6, 7] as exem-
plified by three studies from Kenyatta National hospital
(KNH), a tertiary referral and teaching hospital in
Nairobi, Kenya. A histologic study of 1501 breast speci-
mens conducted by Bjerregaard and Kung’u found that
benign and malignant lesions accounted for 72.2 % and
27.8 % of the diagnosed breast lesions, respectively [8].
A retrospective study of 1172 patient records performed
by Otieno et al. found that fibroadenoma (33.2 %) and
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ductal carcinoma (17.4 %) were the most frequently di-
agnosed types of lesions and 98.9 % of all breast lesions
occurred in female patients [9]. Finally, a prospective
cross-sectional study of 166 breast cancer patients
conducted by Otieno et al. found that 98.8 % of pa-
tients diagnosed with breast cancer were females and
24.1 % of patients had been incorrectly reassured that
their disease was benign prior to being diagnosed
with breast cancer [10].
The primary objective of this study was to deter-
mine the type and sex-specific distribution of breast
lesions diagnosed by cytological evaluation of breast
specimens from patients presenting to KNH with
breast complaints over a four year period. The sec-
ondary objective of this study was to evaluate the
clinical adequacy of narrative reporting of breast cy-
tology results.
Methods
Medical records in the form of breast cytology reports
from 443 consecutive patients presenting to breast or
general surgical clinics at KNH over the period of
January 5, 2010 and March 6, 2014 with palpable breast
lump, nipple discharge, breast pain, nipple retraction,
skin changes, or axillary lymphadenopathy were accessed
from the records department of KNH’s cytology labora-
tory and examined for eligibility. Reports having patient
age and sex, clinical summary, breast cytology sampling
technique, microscopic findings, and conclusive breast
cytology diagnosis were included in the study. Reports
having major typographical errors, clinical history of
breast cancer, cytological diagnosis of secondary breast
diseases, and inconclusive breast cytology results were
excluded from the study. A total of 390 breast cytology
reports satisfied eligibility criteria. All data were analyzed
using Microsoft Excel 2013 and results described using
summary statistics. This single institution study was
approved by the Kenyatta National Hospital/University
of Nairobi Ethics and Research Committee (Ref: KNH-
ERC/UA/189). The need for written or verbal informed
consent was waived by the KNH-ERC.
Table 1 Presenting complaints of study population (n = 390)
Presenting complaint Women Men Total
Palpable breast lump 337 40 377
Nipple discharge 29 0 29
Breast pain 19 8 27
Skin changes 22 0 22
Palpable axillary lymph node(s) 15 0 15
Nipple retraction 5 0 5
Median duration (in months) 11 4.5 8
Fig. 1 Cytological profile of breast lesions diagnosed in women and men (n = 390). Bar chart represents the frequency distribution of all breast
lesions diagnosed from January 2010 to March 2014. NOS: not otherwise specified
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Results
Presenting complaints and diagnosed breast lesions
The mean age of the evaluated patients was 36.0 ± 16.7
(range, 10–90) years and the sex-specific mean age was
34.6 ± 16.2 (range, 10–90) years for women and 48.6 ± 16.2
(range, 15–78) years for men. Breast lesions were most fre-
quently diagnosed in women aged 20–24 years (n = 91) and
50+ years (n = 65), and men aged 50+ years (n = 25). The
presenting complaints are summarized in Table 1. Palpable
breast lump was the most common (96.7 %; n = 377) while
nipple retraction was the least common (1.3 %; n = 5) pre-
senting complaint. The median duration of presenting
complaints in patients was 11 months for women and
4.5 months for men.
The frequency distribution of all diagnosed breast
lesions is shown in Fig. 1. Fibroadenoma (n = 136)
and fibrocystic changes (n = 38) were the most fre-
quently diagnosed benign breast lesions whereas
ductal carcinoma (n = 68) was the most frequently di-
agnosed malignant breast lesion. Other frequently di-
agnosed breast lesions included gynecomastia (n = 33),
benign breast lesions, not otherwise specified (n = 20),
galactocele (n = 12), intraductal papilloma (n = 12),
and fat necrosis (n = 12).
Types of diagnosed breast lesions and sex-specific
distribution
Of the 390 diagnosed breast lesions, 75.9 % (n = 296)
were neoplastic and 24.1 % (n = 94) were non-neoplastic.
Of the neoplastic breast lesions, 72.3 % (n = 214) were
benign and 27.7 % (n = 82) were malignant. Thus, the
benign-to-malignant ratio was 2.6:1. Of the non-
neoplastic breast lesions, 48.9 % (n = 46) were associated
with inflammation whereas 51.1 % (n = 48) were not
associated with inflammation.
The sex-specific distribution of breast lesions diag-
nosed by breast cytology (Table 2) shows that 98 % of
the neoplastic and 63.8 % of the non-neoplastic breast
lesions occurred in women. Fibroadenoma (38.9 %),
ductal carcinoma (18 %), and fibrocystic changes
(10.9 %) were the most frequently diagnosed breast
lesions in women. Fibroadenoma affected women aged
10–57 years, ductal carcinoma affected women aged
21–90 years, and fibrocystic changes affected women
aged 21–67 years. Lobular carcinoma affected women
aged 37–83 years and accounted for 1.7 % of the
breast lesions diagnosed in women.
In men, 2 % of the breast lesions were neoplastic
whereas 36.2 % were non-neoplastic. Gynecomastia
(82.5 %) was the most frequent breast lesion in men and
was diagnosed in men aged 17–67 years. Ductal carcin-
oma (12.5 %) was the only neoplastic breast lesion and
was diagnosed in men aged 52–68 years. Taken together,
89.7 % (n = 350) of breast lesions occurred in females,
while 10.3 % (n = 40) of breast lesions occurred in males,
giving rise to a female-to-male ratio of 8.8:1.
Clinical adequacy of narrative reporting of breast
cytology results
Results from the 390 breast cytology reports evaluated
were reported in descriptive narrative format. Based on
the findings from Abati and Simsir’s review [11] of the
1996 National Cancer Institute Consensus Panel Criteria
for optimal performance and reporting of breast fine-
needle aspiration [12], breast cytology reports from
KNH were found clinically inadequate and requiring
improvement. All the reports lacked standardized diag-
nostic terminology and did not clearly report clinical
Table 2 Sex-specific distribution of breast lesions diagnosed by
breast cytology
Cytological diagnoses Women Men Total
n (%) n (%) n (%)
A. Neoplastic
Ductal carcinoma 63 (18 %) 5 (12.5 %) 68 (17.4 %)
Fibroadenoma 136 (38.9 %) 0 (0 %) 136 (34.9 %)
Fibrocystic changes 38 (10.9 %) 0 (0 %) 38 (9.7 %)
Benign breast lesion, NOS 19 (5.4 %) 1 (2.5 %) 20 (5.1 %)
Intraductal papilloma 12 (3.4 %) 0 (0 %) 12 (3.1 %)
Lobular carcinoma 6 (1.7 %) 0 (0 %) 6 (1.5 %)
Malignant breast lesion 5 (1.4 %) 0 (0 %) 5 (1.3 %)
Suspicious for malignancy 3 (0.9 %) 0 (0 %) 3 (0.8 %)
Fibroadenomatosis 2 (0.6 %) 0 (0 %) 2 (0.5 %)
Intraductal papilloma with
fibrocystic changes
2 (0.6 %) 0 (0 %) 2 (0.5 %)
Fibroadenoma with
granulomatous mastitis
1 (0.3 %) 0 (0 %) 1 (0.3 %)
Ductal hyperplasia 1 (0.3 %) 0 (0 %) 1 (0.3 %)
Benign breast lesion with
atypia
1 (0.3 %) 0 (0 %) 1 (0.3 %)
Benign proliferative breast
disease
1 (0.3 %) 0 (0 %) 1 (0.3 %)
B. Non-neoplastic
Gynecomastia 0 (0 %) 33 (82.5 %) 33 (8.5 %)
Galactocele 12 (3.4 %) 0 (0 %) 12 (3.1 %)
Fat necrosis 12 (3.4 %) 0 (0 %) 12 (3.1 %)
Breast abscess 9 (2.6 %) 0 (0 %) 9 (2.3 %)
Inflammatory breast lesion 9 (2.6 %) 1 (2.5 %) 10 (2.6 %)
Mammary duct ectasia 8 (2.3 %) 0 (0 %) 8 (2.1 %)
Acute mastitis 3 (0.9 %) 0 (0 %) 3 (0.8 %)
Cystic breast mass 3 (0.9 %) 0 (0 %) 3 (0.8 %)
Granulomatous mastitis 3 (0.9 %) 0 (0 %) 3 (0.8 %)
Breast ulcer 1 (0.3 %) 0 (0 %) 1 (0.3 %)
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and imaging findings, lesion localization technique, spe-
cimen adequacy, triple test assessment findings, and
post-cytology recommendations. To address these limi-
tations, a synoptic reporting format (Fig. 2) has been de-
veloped and is recommended for adoption by KNH. The
recommended synoptic reporting format clearly shows
the clinical and imaging findings, lesion localization
technique, triple test score, and post-cytology recom-
mendations and also incorporates the National Health
Service Breast Screening Programme’s (NHSBSP) breast
cytology diagnostic categories: inadequate (C1), benign
(C2), atypia probably benign (C3), suspicious of malig-
nancy (C4), and malignant (C5) [13, 14]. Notably, inte-
gration of triple test findings to the recommended
synoptic reporting format is expected to facilitate clinical
decision-making by stratifying patients into three
evidence-based groups [4, 15]: patients eligible for
scheduled breast imaging follow-up based on triple test
scores of 3–4, patients eligible for excisional biopsy and
cytohistologic correlation based on triple test scores of
Fig. 2 Recommended synoptic reporting format for recording breast cytology results. The recommended synoptic reporting format consists of
clinically relevant parameters in checklist form with minimal use of narrative and incorporates standardized diagnostic terminology. FNA: fine-needle
aspiration; LIQ: lower inner quadrant; LOQ: lower outer quadrant; UIQ: upper inner quadrant; UOQ: upper outer quadrant
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5–7, and patients eligible for immediate surgical inter-
vention or definitive therapy based on triple test scores
of 8–9 and overall clinical impression.
Discussion
The primary objective of the present study was to deter-
mine the type and distribution of breast lesions diag-
nosed by breast cytology in Kenyan patients presenting
to a tertiary referral hospital over a four year period. Of
the total diagnosed breast lesions, 72.3 % were benign,
which is in agreement with findings by Bjerregaard and
Kung’u [8] and Panjvani et al. [16]. Fibroadenoma was
the most frequently diagnosed lesion in pre-menopausal
women, while gynecomastia was the most frequently
diagnosed lesion in men, consistent with both prospect-
ive and retrospective studies from Uganda [7], India
[16], and Pakistan [17]. Palpable breast lump (377 pa-
tients) was the most common presenting complaint,
which is consistent with previous findings in Kenya [10]
and elsewhere [2, 17, 18]. Nipple discharge (29 patients)
was the second most common presenting complaint.
Although nipple discharge is often suggestive of breast
malignancy when unilateral, bloody, or associated with a
breast lump [1, 19, 20], its diagnostic value is controver-
sial [2, 19–22]. Consequently, more studies are needed
to establish the suitability of triple test assessment for
diagnostic evaluation of patients presenting with nipple
discharge. Finally, despite the consistency of present
findings with existing literature, the prevalence of breast
diseases in Kenya may be underestimated by the retro-
spective study design. Population-based studies are
therefore needed to fully characterize the epidemiology
of breast diseases in Kenya.
The secondary objective of this study was to assess the
clinical adequacy of narrative reporting of breast
cytology results. All of the breast cytology reports evalu-
ated in this study used a non-standardized descriptive
narrative format instead of a standardized checklist-
based synoptic format [23]. Synoptic reporting of path-
ology results is gaining acceptance in Asia and North
America. A synoptic report was recently developed and
used in Japan to accurately report breast cytology results
in a series of 3439 cases [24]. Additionally, a cancer
reporting project conducted in Ontario, Canada by
Srigley et al. found that a province-wide implementation
of a synoptic reporting format generated more complete
reports and led to increased rates of cancer reporting
[25]. Our findings alongside those from other investiga-
tors suggest that evidence-based synoptic reporting
combined with active monitoring of results may be
superior to traditional narrative reporting. Therefore,
adoption of the recommended synoptic reporting format
by KNH is expected to enhance the clinical utility of
diagnostic breast cytology and promote standardization
of breast pathology practices in Kenya.
Conclusions
This study found that breast cytology effectively diagnosed
neoplastic and non-neoplastic breast lesions. Neoplastic
breast lesions occurred more frequently in women, while
non-neoplastic lesions occurred more frequently in men.
To address the limitations associated with narrative
reporting of breast cytology results, KNH should adopt
the recommended synoptic reporting format.
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